Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and efficacy of Irinotecan Bead
in combination with intravenous chemotherapy versus intravenous chemotherapy alone in the
treatment of unresectable liver metastases in patients with colorectal cancer. The results of
this study are intended to be used in support of a PMA application for a combination device